Ciloxan 3 mg/g øjensalve Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ciloxan 3 mg/g øjensalve

novartis healthcare a/s - ciprofloxacinhydrochlorid, vandfrit - øjensalve - 3 mg/g

Ciloxan 3 mg/ml øredråber, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ciloxan 3 mg/ml øredråber, opløsning

novartis healthcare a/s - ciprofloxacinhydrochlorid, vandfrit - øredråber, opløsning - 3 mg/ml

Clarithromycin "Accord" 250 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clarithromycin "accord" 250 mg filmovertrukne tabletter

accord healthcare b.v. - clarithromycin - filmovertrukne tabletter - 250 mg

Ondansetron "Accord" 2 mg/ml injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

ondansetron "accord" 2 mg/ml injektions-/infusionsvæske, opløsning

accord healthcare b.v. - ondansetronhydrochloriddihydrat - injektions-/infusionsvæske, opløsning - 2 mg/ml

Tenofovirdisoproxil "Accord" 245 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

tenofovirdisoproxil "accord" 245 mg filmovertrukne tabletter

accord healthcare b.v. - tenofovirdisoproxil - filmovertrukne tabletter - 245 mg

Allopurinol "Accord" 100 mg tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

allopurinol "accord" 100 mg tabletter

accord healthcare b.v. - allopurinol - tabletter - 100 mg

Gefitinib "Accord" 250 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

gefitinib "accord" 250 mg filmovertrukne tabletter

accord healthcare b.v. - gefitinib - filmovertrukne tabletter - 250 mg

Dasatinib Accordpharma Den Europæiske Union - dansk - EMA (European Medicines Agency)

dasatinib accordpharma

accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase.  chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib.  ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib.  newly diagnosed ph+ all in combination with chemotherapy.

Clinzoyl 10+50 mg/g gel Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

clinzoyl 10+50 mg/g gel

morningside healthcare (malta) limited - benzoylperoxid, vandig, clindamycinphosphat - gel - 10+50 mg/g

Rosuvastatin "Accord" 10 mg filmovertrukne tabletter Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

rosuvastatin "accord" 10 mg filmovertrukne tabletter

accord healthcare b.v. - rosuvastatin calcium - filmovertrukne tabletter - 10 mg